Scott Ferguson Sachem Head Capital Management
Scott Ferguson is the founder of Sachem Head Capital Management, an activist and fundamental equity firm. He previously worked at firms including Corvex and built a reputation for research-driven campaigns at public companies. Ferguson’s filings and activist situations are followed closely in event-driven and engagement-oriented investing circles.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KATE
Kate Spade & Company
KATE
|
+$131M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 3 |
Humana
HUM
|
+$77.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$76.8M |
| 5 |
CIT
CIT Group Inc.
CIT
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBA Communications
SBAC
|
+$184M |
| 2 |
CDK
CDK Global, Inc.
CDK
|
+$120M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$38.7M |
| 4 |
Charter Communications
CHTR
|
+$36.5M |
| 5 |
SHPG
Shire pic
SHPG
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.27% |
| 2 | Communication Services | 19.09% |
| 3 | Healthcare | 15.3% |
| 4 | Industrials | 6.58% |
| 5 | Financials | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Autodesk
ADSK
$53.6B
| $1.11B | 36.12% |
12,890,000
| – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $205M | 6.65% |
1,650,000
+305,000
| +23% | +$36.5M |
|
3
Dell
DELL
$286B
| $199M | 6.46% |
11,081,670
+2,707,583
| +32% | +$47.2M |
|
4
Salesforce
CRM
$171B
| $176M | 5.69% |
2,130,000
| – | – |
|
5
Alphabet (Google) Class A
GOOGL
$4.22T
| $174M | 5.63% |
4,100,000
| – | – |
|
|
6
Charter Communications
CHTR
$17.9B
| $169M | 5.46% |
515,000
-114,692
| -18% | -$36.5M |
|
7
Comcast
CMCSA
$95.3B
| $165M | 5.35% |
4,390,000
| – | – |
|
|
TMX
8
DELISTED
Terminix Global Holdings, Inc.
TMX
| $161M | 5.22% |
5,755,515
| – | – |
|
|
KATE
9
DELISTED
Kate Spade & Company
KATE
| $145M | 4.7% |
+6,250,000
| New | +$131M |
|
10
Bank of America
BAC
$431B
| $117M | 3.81% |
4,978,000
| – | – |
|
|
11
Bristol-Myers Squibb
BMY
$137B
| $113M | 3.65% |
+2,070,000
| New | +$114M |
|
|
12
Meta Platforms (Facebook)
META
$1.4T
| $81.7M | 2.65% |
+575,000
| New | +$76.8M |
|
|
13
Humana
HUM
$45.5B
| $77.3M | 2.5% |
+375,000
| New | +$77.5M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
| $77M | 2.49% |
635,000
-300,000
| -32% | -$38.7M |
|
|
CIT
15
DELISTED
CIT Group Inc.
CIT
| $69.5M | 2.25% |
+1,620,000
| New | +$68.6M |
|
|
CDK
16
DELISTED
CDK Global, Inc.
CDK
| $42.3M | 1.37% |
650,000
-1,869,305
| -74% | -$120M |
|
|
17
SBA Communications
SBAC
$19.4B
| – | – |
-1,785,000
| Closed | -$184M |
|
|
SHPG
18
DELISTED
Shire pic
SHPG
| – | – |
-175,000
| Closed | -$29.8M |
|
Similar funds
Scott Ferguson's Q1 2017 Portfolio in Review
As of Q1 2017, Scott Ferguson held 18 positions worth $3.09B, up 18% from $2.61B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Scott Ferguson deployed $142M of net new capital in Q1 2017, opening 5 new positions and adding to 2 existing holdings. Its largest new stake was Kate Spade & Company: 6,250,000 shares worth $145M.
By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 47% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was CDK Global, Inc., an estimated $120M trimmed.
- Scott Ferguson's largest Q1 2017 buy was Kate Spade & Company: 6,250,000 shares worth $145M.
- Scott Ferguson added most to Dell in Q1 2017, an estimated $47.2M increase.
- Scott Ferguson's biggest Q1 2017 reduction was CDK Global, Inc., cutting an estimated $120M.
- Scott Ferguson fully exited SBA Communications in Q1 2017, selling an estimated $184M.
- Scott Ferguson's ten largest holdings make up 85% of its $3.09B portfolio in Q1 2017.
- Scott Ferguson opened 5 new positions and closed 2 in Q1 2017.
- Scott Ferguson's portfolio value rose 18% quarter-over-quarter to $3.09B.
Based on Sachem Head Capital Management's 13F filing for Q1 2017, filed 12 May 2017.